Market Tracker

11/21 6:05pm ET

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

6.50
Data as of Nov 21
 -0.12 / -1.81%
Today’s Change
5.22
Today|||52-Week Range
13.64
-42.53%
Year-to-Date

Today’s Trading

Previous close6.62
Today’s open6.75
Day’s range6.37 - 6.75
Volume338,114
Average volume (3 months)662,099
Market cap$284.1M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+60.93%
Earnings growth (this year)-64.41%
Earnings growth (next 5 years)+48.90%
Revenue growth (last year)+1,132.33%
P/E ratio325.0
Price/Sales15.24
Price/Book3.82

Competitors

 Today’s
change
Today’s
% change
POZNPOZEN Inc-0.07-0.78%
PRTKParatek Pharmaceutic...+0.06+0.31%
AMBIAmbit Biosciences Co...----
SVASinovac Biotech Ltd+0.04+0.80%
Data as of 4:00pm ET, 11/21/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$29.5M
Annual profit (last year)-$23.4M
Net profit margin-79.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Richard A. King
Chief Financial Officer
Timothy E. Morris
Corporate headquarters
Redwood City, California

Forecasts